Ep. 55 Updates in Colorectal Cancer Management: Insights ...

What this episode covers

How will the newest colorectal cancer trial results discussed at the 2026 ASCO GI Cancers Symposium in San Francisco impact patient care and therapeutic strategies? Medical oncologists Dr. Shruti Patel and Dr. Jun Gong dissect evidence from multiple practice-changing studies, translating complex data into practical recommendations. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction01:50 - BREAKWATER Trial for Metastatic CRC11:31 - COMMIT Trial for Metastatic CRC dMMR17:34 - STELLAR-303 Trial for Refractory CRC26:03 - ALASCCA Trial on Adjuvant Low Dose Aspirin in CRC31:29 - CHALLENGE Trial on Structured Exercise Programs38:48 - ATOMIC Trial on Adjuvant Immunotherapy44:34 - The Role of GLP-1s in CRC Prevention --- More about this episode Dr. Patel and Dr. Gong cover key findings and takeaways from recent colorectal cancer studies, including BREAKWATER, COMMIT, STELLAR-303, ALASCCA, CHALLENGE, and ATOMIC. BREAKWATER evaluates first-line targeted therapy combinations in BRAF V600E–mutant metastatic CRC, demonstrating improved response rates and progression-free survival with the addition of encorafenib-based regimens. COMMIT investigates the role of immunotherapy with or without chemotherapy in dMMR metastatic CRC, helping clarify whether upfront chemotherapy adds benefit to checkpoint blockade in this population.STELLAR-303 examines a novel therapeutic option in refractory CRC, comparing a new agent against standard therapies and showing modest survival benefit in heavily pretreated patients. ALASCCA assesses the impact of adjuvant low-dose aspirin in biomarker-selected CRC patients, suggesting improved disease-free survival in patients with PI3K pathway alterations. CHALLENGE evaluates structured exercise interventions in the post-treatment setting, demonstrating that increased physical activity is associated with improved disease-free survival and overall outcomes.ATOMIC explores the addition of immunotherapy to standard adjuvant chemotherapy in resected dMMR CRC, supporting a potential shift toward incorporating checkpoint inhibitors in earlier-stage disease. --- Resources BREAKWATER Trial Cohort 3 Studyhttps://ascopubs.org/doi/10.1200/JCO.2026.44.2_suppl.13 COMMIT Phase 3 Trialhttps://ascopubs.org/doi/10.1200/JCO.2026.44.2_suppl.14 STELLAR-303 Phase 3 Trialhttps://pubmed.ncbi.nlm.nih.gov/41130252/ Immunotherapy Efficacy in Mismatch Repair-Proficient Colorectal Cancer Patients With and Without Liver Metastaseshttps://ascopubs.org/doi/10.1200/JCO-25-01044 ALASCCA Trialhttps://clinicaltrials.gov/study/NCT02647099?tab=studyCHALLENGE Phase 3 Trial https://ascopubs.org/doi/10.1200/JCO.2025.43.17_suppl.LBA3510Regular Physical Activity Can Help Manage CRC-Related Fatiguehttps://dailynews.ascopubs.org/do/regular-physical-activity-can-help-manage-crc-related-fatigue ATOMIC Phase 3 Trialhttps://ascopubs.org/doi/10.1200/JCO.2025.43.17_suppl.LBA1 GLP-1 Receptor Agonist vs Aspiring for Primary Prevention of Colorectal Cancerhttps://ascopubs.org/doi/10.1200/JCO.2026.44.2_suppl.18 ---BackTable Tumor Board is the go-to multidisciplinary podcast for medical oncologists, surgical oncologists, and other healthcare professionals that play an active role in cancer care. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

API Intersection Stoplight Building a successful API requires more than just coding. It starts with collaborative design, focuses on creating a great developer experience, and ends with getting your company on board, maintaining consistency, and maximizing your API’s profitability.In the API Intersection, you’ll learn from experienced API practitioners who transformed their organizations, and get tangible advice to build quality APIs with collaborative API-first design.Jason Harmon brings over a decade of industry-recognized REST API experience to discuss topics around API design, governance, identity/auth versioning, and more.They’ll answer listener questions, and discuss best practices on API design (definition, modeling, grammar), Governance (multi-team design, reviewing new API’s), Platform Transformation (culture, internal education, versioning) and more.They’ll also chat with experienced API practitioners from a wide array of industries to draw out practical takeaways and insights you can use.H PDF feed of Interpreter: A Journal of Latter-day Saint Faith and Scholarship PDF feed of Interpreter: A Journal of Latter-day Saint Faith and Scholarship The Interpreter Foundation is a nonprofit educational organization focused on the scriptures of The Church of Jesus Christ of Latter-day Saints (the Book of Mormon, the Pearl of Great Price, the Bible, and the Doctrine and Covenants), early LDS history, and related subjects. All publications in its journal, Interpreter: A Journal of Latter-day Saint Faith and Scholarship, are peer-reviewed and made available as free internet downloads or through at-cost print-on-demand services. Other posts on the website are not necessarily peer-reviewed, but are approved by Interpreter’s Executive Board.Our goal is to increase understanding of scripture through careful scholarly investigation and analysis of the insights provided by a wide range of ancillary disciplines, including language, history, archaeology, literature, culture, ethnohistory, art, geography, law, politics, philosophy, statistics, etc. Interpreter will also publish articles advocating the authenticity and historicity Passive Investing Podcast The Real Estate Women The Passive Investing Podcast is a round table discussion where we teach you how to create a stream of passive income through Multi Family investing. Crystal, Candy, Colleen & Tamara dive into the classroom, board room and living room on Multi Family real estate investing, with Guests Matt Pichney, Rod Khleif, and Julie Holly pulling up a chair to share stories and insight on their areas of expertise. Whether you’re trying to jump into real estate to free yourself from the grind of the 9-5, to build a stream of passive income or to create generational wealth, join us at the table! Brasher Warning Brasher Warning Brasher Warning: Exploring the Skies, One Close Call at a Time: Take a deep dive into the intense world of aviation incidents with Brasher Warning, a podcast that explores the stories behind near misses, full-blown accidents, and everything in between. As a busy Chicago-based air traffic controller, husband, and father of two amazing girls, my time is limited, but my passion for aviation safety has never wavered. Thanks to cutting-edge AI, I’ve discovered a way to bring this passion back into my life—and now, into yours. Each episode unpacks real-life aviation events using detailed reports, including those from the National Transportation Safety Board (NTSB), weaving them into seamless, digestible narratives. Whether on my way to work, during a quick break, or while I’m getting ready for the day, AI allows me to analyze mountains of data and transform it into compelling stories that inform and entertain. And now I’m sharing that with you. Whether you’re an aviation enthusiast, a cur

Frequently Asked Questions

How long is this episode of BackTable Tumor Board?

This episode is 50 minutes long.

When was this BackTable Tumor Board episode published?

This episode was published on April 14, 2026.

What is this episode about?

How will the newest colorectal cancer trial results discussed at the 2026 ASCO GI Cancers Symposium in San Francisco impact patient care and therapeutic strategies? Medical oncologists Dr. Shruti Patel and Dr. Jun Gong dissect evidence from multiple...

Can I download this BackTable Tumor Board episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.